诺氟沙星
规格或纯度:
分析标准品
- CAS编号: 70458-96-7
- 分子式: C16H18FN3O3
- 分子量: 319.33
- MDL号: MFCD00079532
- PubChem编号: 4539
有货
规格或纯度 | 分析标准品 |
---|---|
英文名称 | Norfloxacin |
别名 | 氟哌酸,1-乙基-6-氟-1,4-二氢-4-氧代-7-(1-哌嗪基)-3-喹啉羧酸 |
英文别名 | 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-piperazino-3-quinolinecarboxylic acid |
应用 | 氟哌酸昌日本杏林公司1978年开发的第三代喹诺酮类抗菌剂。具有抗菌谱广、抗菌力强的特点。对大肠杆菌、肺炎杆菌、产气杆菌、阴沟杆菌、变形杆菌、沙门氏杆菌、志贺氏菌属、枸橼酸杆菌属及沙雷氏菌属等遥植树菌具有强大的抗菌作用。 |
储存温度 | 2-8°C储存 |
运输条件 | 冰袋运输 |
产品介绍 |
易溶于酸,碱溶液,极微溶于水和醇。无臭、味微苦。氟哌酸昌日本杏林公司1978年开发的第三代喹诺酮类抗菌剂。具有抗菌谱广、抗菌力强的特点。对大肠杆菌、肺炎杆菌、产气杆菌、阴沟杆菌、变形杆菌、沙门氏杆菌、志贺氏菌属、枸橼酸杆菌属及沙雷氏菌属等遥植树菌具有强大的抗菌作用。 |
IUPAC Name | 1-ethyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid |
---|---|
INCHI | InChI=1S/C16H18FN3O3/c1-2-19-9-11(16(22)23)15(21)10-7-12(17)14(8-13(10)19)20-5-3-18-4-6-20/h7-9,18H,2-6H2,1H3,(H,22,23) |
InChi Key | OGJPXUAPXNRGGI-UHFFFAOYSA-N |
Canonical SMILES | CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O |
分子式 |
C16H18FN3O3 |
PubChem CID | 4539 |
分子量 | 319.33 |
Antibiotic DB | 2036 |
---|---|
PubChem CID | 4539 |
ChEMBL Ligand | CHEMBL9 |
ChEBI | CHEBI:100246 |
DrugBank Ligand | DB01059 |
DrugCentral Ligand | 1967 |
CAS Registry No. | 70458-96-7 |
密度 | 1.344 |
---|---|
熔点 | 227-228°C |
象形图 |
Health Hazard Corrosive Harmful |
---|---|
信号词 | Danger |
危险声明 |
H319: Causes serious eye irritation H318: Causes serious eye damage H361: Suspected of damaging fertility or the unborn child |
预防措施声明 | P305+P351+P338,P280,P405,P501,P203,P264+P265,P305+P354+P338,P318,P317,P337+P317 |
Merck Index | 6700 |
Ligand ID | 12408 |
---|---|
名称 | norfloxacin |
别名 | Chibroxin® |
类别 | Synthetic organic |
学名 | 1-ethyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid |
生物活性评价 |
Norfloxacin has potent activity against most Enterobacteriaceae (MIC90 0.25 μg/ml), Haemophilus influenzae (MIC90 0.12 μg/ml) and Neisseria gonorrhoeae (MIC90 0.016 μg/ml). The drug is less active against Staphylococci (MIC90 2 μg/ml) and Streptococci (MIC90 4 μg/ml) |
评价 |
Norfloxacin is a fluoroquinolone compound with broad-spectrum antibacterial activity |
1. King A, Warren C, Shannon K, Phillips I. (1982) In vitro antibacterial activity of norfloxacin (MK-0366).. Antimicrob Agents Chemother, 21 (4): (604-7). [PMID:6211139] |
2. Ito A, Hirai K, Inoue M, Koga H, Suzue S, Irikura T, Mitsuhashi S. (1980) In vitro antibacterial activity of AM-715, a new nalidixic acid analog.. Antimicrob Agents Chemother, 17 (2): (103-8). [PMID:6446258] |